166 related articles for article (PubMed ID: 34493241)
1. CML derived exosomes promote tumor favorable functional performance in T cells.
Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
[TBL] [Abstract][Full Text] [Related]
2. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
[TBL] [Abstract][Full Text] [Related]
4. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.
Corrado C; Raimondo S; Saieva L; Flugy AM; De Leo G; Alessandro R
Cancer Lett; 2014 Jun; 348(1-2):71-6. PubMed ID: 24657661
[TBL] [Abstract][Full Text] [Related]
6. Released Exosomes Contribute to the Immune Modulation of Cord Blood-Derived Stem Cells.
Hu W; Song X; Yu H; Sun J; Zhao Y
Front Immunol; 2020; 11():165. PubMed ID: 32161585
[No Abstract] [Full Text] [Related]
7. The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen.
Li Y; Yang L; Chen S; Zhang Y; Wu X
Hematology; 2005 Oct; 10(5):387-92. PubMed ID: 16273727
[TBL] [Abstract][Full Text] [Related]
8. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion.
Mineo M; Garfield SH; Taverna S; Flugy A; De Leo G; Alessandro R; Kohn EC
Angiogenesis; 2012 Mar; 15(1):33-45. PubMed ID: 22203239
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.
Liu Y; Song B; Wei Y; Chen F; Chi Y; Fan H; Liu N; Li Z; Han Z; Ma F
Cytotherapy; 2018 Feb; 20(2):181-188. PubMed ID: 29269240
[TBL] [Abstract][Full Text] [Related]
10. Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes.
Feng DQ; Huang B; Li J; Liu J; Chen XM; Xu YM; Chen X; Zhang HB; Hu LH; Wang XZ
Asian Pac J Cancer Prev; 2013; 14(12):7501-8. PubMed ID: 24460325
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
Zhang X; Tu H; Yang Y; Jiang X; Hu X; Luo Q; Li J
J Biol Chem; 2019 Aug; 294(32):12167-12179. PubMed ID: 31235520
[TBL] [Abstract][Full Text] [Related]
12. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
[No Abstract] [Full Text] [Related]
14. The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker.
Kang KW; Jung JH; Hur W; Park J; Shin H; Choi B; Jeong H; Kim DS; Yu ES; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim HK; Hong S; Park JH; Choi Y; Park Y; Kim BS
Anticancer Res; 2018 Jul; 38(7):3935-3942. PubMed ID: 29970515
[TBL] [Abstract][Full Text] [Related]
15. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma cell-derived exosomes promote favorable tumor functional performance by polarizing macrophages toward M2-like cells.
Razi B; Soleimani M; Soufi-Zomorrod M; Adeli A; Davoudi N
APMIS; 2023 Aug; 131(8):381-393. PubMed ID: 36867046
[TBL] [Abstract][Full Text] [Related]
17. Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation.
Fathi E; Farahzadi R; Valipour B; Sanaat Z
PLoS One; 2019; 14(4):e0215678. PubMed ID: 31009502
[TBL] [Abstract][Full Text] [Related]
18. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
[TBL] [Abstract][Full Text] [Related]
19. [Effect of up-regulated expression of tumor suppressor gene p14(ARF) on apoptosis of chronic myeloid leukemia cells].
Bai YS; Liu J; Liu XH; Dai EY; Sun BT; Lu ZX
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):512-5. PubMed ID: 23827110
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
